Home Market News Micro Cap Stocks Leslie’s Lessons: Pre-Market Blues Hit Big Stocks, Including Leslie’s, Las Vegas Sands, Verve Therapeutics, and More

Leslie’s Lessons: Pre-Market Blues Hit Big Stocks, Including Leslie’s, Las Vegas Sands, Verve Therapeutics, and More

0
Leslie’s Lessons: Pre-Market Blues Hit Big Stocks, Including Leslie’s, Las Vegas Sands, Verve Therapeutics, and More

The early bird may catch the worm, but some stocks are catching an early pounding in today’s pre-market trading. Dow Jones futures are soaring, but that’s cold comfort for big names like Leslie’s, Las Vegas Sands, Verve Therapeutics, and a plethora of others taking a beating in early trading today.

Leslie’s, Inc. (LESL) is the latest casualty of the pre-market slump, tumbling 15% to $4.95 after reporting a lackluster fourth-quarter performance. While the company beat revenue estimates, the earnings miss sent investors running for cover.

Other big names feeling the pain include Verve Therapeutics, Inc. (VERV) shedding 11.2%, Cabaletta Bio, Inc. (CABA) dropping 7.8%, Okta, Inc. (OKTA) declining 7.3%, Cool Company Ltd. (CLCO) falling 6.3%, Las Vegas Sands Corp. (LVS) declining 5.9%, Koninklijke Philips N.V. (PHG) falling 4.3%, and Farfetch Limited (FTCH) down 3.8%.

There’s a lot of red on the trading floor, and early indications suggest a rough day ahead for many big players. This may be a time for caution, and investors should tread carefully as they navigate these choppy pre-market waters.